Featured 13F manager
Patient Capital Management, LLC Samantha McLemore
Baltimore, MD 19 processed 13Fs on this site · 2021 Q4–2026 Q2
- $3.1B
- 39 Positions
- 2026 Q2
- +11.5% QoQ
- Top 5 30.5%
Portfolio
top 5 30.5% · top 10 51.3%
- RPRX - Royalty Pharma · CLASS A 6.6%
- C - Citigroup 6.4%
- GOOGL - Alphabet · CL A 6.2%
- UNH - Unitedhealth Group 6.0%
- AMZN - Amazon 5.3%
- NVDA - Nvidia 4.6%
- CVS - Cvs Health 4.2%
- NCLH - Norwegian Cruise Line 4.2%
- QXO - QXO Inc 4.0%
- ET - Energy Transfer L P 3.8%
- IAC - People 3.7%
- PGEN - Precigen 3.6%
- Other 41.4%
AUM over time
Book
| EXPE - Expedia Group | 7.52% | Reduce −3.7% | 935,490 | $151.79 | $142M | −35,547 | +$42M |
| AMZN - Amazon | 5.81% | Reduce −7.2% | 722,233 | $151.94 | $110M | −56,394 | +$11M |
| OMF - Onemain | 5.60% | Reduce −0.3% | 2,148,977 | $49.20 | $106M | −5,899 | +$19M |
| C - Citigroup | 5.15% | Add +0.4% | 1,889,331 | $51.44 | $97M | +6,902 | +$20M |
| GOOGL - Alphabet · CL A | 4.44% | Reduce −4.9% | 600,588 | $139.69 | $84M | −31,102 | +$1M |
| ET - Energy Transfer L P | 4.10% | Reduce −0.1% | 5,610,917 | $13.80 | $77M | −4,986 | −$1M |
| DAL - Delta Air Lines Del | 4.08% | Add +4.8% | 1,913,428 | $40.23 | $77M | +87,939 | +$9M |
| UBS - UBS Group AG | 4.01% | Reduce −1.3% | 2,450,937 | $30.90 | $76M | −31,675 | +$15M |
| IAC - IAC Inc | 3.79% | Add +7.7% | 1,366,938 | $52.38 | $72M | +97,938 | +$8M |
| GM - General Mtrs | 3.55% | Add +15.1% | 1,866,367 | $35.92 | $67M | +245,062 | +$14M |
| META - Meta Platforms · CL A | 3.53% | Reduce −0.5% | 188,424 | $353.96 | $67M | −928 | +$10M |
| MAT - Mattel | 3.29% | Reduce −6.6% | 3,289,071 | $18.88 | $62M | −233,767 | −$16M |
| NCLH - Norwegian Cruise | 2.69% | Reduce 0.0% | 2,533,585 | $20.04 | $51M | −1,012 | +$9M |
| UAL - United Airls | 2.67% | Add +11.9% | 1,221,053 | $41.26 | $50M | +129,981 | +$4M |
| CVS - Cvs Health | 2.51% | Reduce −0.7% | 600,977 | $78.96 | $47M | −4,143 | +$5M |
| JPM - Jpmorgan Chase & | 2.42% | Reduce −12.6% | 268,411 | $170.10 | $46M | −38,707 | +$1M |
| GOOS - Canada Goose | 2.41% | Add +16.0% | 3,842,824 | $11.85 | $46M | +529,177 | −$3M |
| BABA - Alibaba Group | 2.37% | Reduce −9.1% | 576,464 | $77.51 | $45M | −57,661 | −$10M |
| TNL - Travel Plus Leisure | 2.32% | Reduce −10.4% | 1,122,287 | $39.09 | $44M | −130,049 | −$2M |
| KOS - Kosmos Energy | 2.26% | Add +19.7% | 6,363,423 | $6.71 | $43M | +1,046,091 | −$797K |
| COF - Capital One Finl | 2.24% | Reduce −11.9% | 321,892 | $131.12 | $42M | −43,491 | +$7M |
| COIN - Coinbase Global · CL A | 2.14% | Reduce −47.4% | 232,022 | $173.92 | $40M | −209,248 | +$7M |
| CROX - Crocs | 2.09% | New | 422,010 | $93.41 | $39M | +422,010 | +$39M |
| PTON - Peloton Interactive · CL A | 2.00% | Add +32.7% | 6,196,285 | $6.09 | $38M | +1,527,471 | +$14M |
| SOFI - SOFI Technologies | 1.99% | Add +1.3% | 3,776,542 | $9.95 | $38M | +48,004 | +$8M |
| UBER - UBER Technologies | 1.90% | Reduce −36.3% | 581,733 | $61.57 | $36M | −331,684 | −$6M |
| RPRX - Royalty Pharma · CLASS A | 1.87% | New | 1,254,780 | $28.09 | $35M | +1,254,780 | +$35M |
| FISV - Fiserv | 1.81% | Reduce −5.2% | 256,679 | $132.84 | $34M | −13,947 | +$4M |
| ILMN - Illumina | 1.78% | New | 240,678 | $139.24 | $34M | +240,678 | +$34M |
| SDRL - Seadrill 2021 | 1.66% | New | 662,574 | $47.28 | $31M | +662,574 | +$31M |
| WST - Western Alliance Bancorp | 1.59% | Reduce −0.3% | 456,883 | $65.79 | $30M | −1,472 | +$9M |
| PGEN - Precigen | 1.13% | Add +16.2% | 15,983,700 | $1.34 | $21M | +2,230,524 | +$2M |
| EXE - Chesapeake Energy | 1.12% | Reduce −14.1% | 273,711 | $76.94 | $21M | −45,034 | −$6M |
| CLF - Cleveland-Cliffs | 1.11% | Reduce −19.9% | 1,027,036 | $20.42 | $21M | −254,658 | +$939K |
| RKT - Rocket Cos · CL A | 0.27% | Reduce −10.1% | 356,677 | $14.48 | $5M | −40,000 | +$2M |
| Karuna Therapeutics | 0.19% | Reduce −93.4% | 11,631 | $316.50 | $4M | −164,621 | −$26M |
| LEN.B — · CL B | 0.09% | Hold | 12,500 | $134.05 | $2M | — | — |
| FANG - Diamondback Energy | 0.08% | Hold | 10,000 | $155.08 | $2M | — | — |
| VNT - Vontier | 0.07% | Hold | 40,000 | $34.55 | $1M | — | — |
| TEVA - Teva Pharmaceutical Inds | 0.06% | Reduce −20.0% | 100,000 | $10.44 | $1M | −25,000 | −$231K |
| SPY - Spdr S&P 500 ETF Tr | 0.05% | New | 2,091 | $475.38 | $994K | +2,091 | +$994K |
| BRLT - Brilliant Earth Group · CL A | 0.05% | Hold | 250,000 | $3.72 | $930K | — | — |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2023 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Splunk | 2.49% | Exit | 0 | $146.25 | $42M | −290,196 | −$42M |
| OVV - Ovintiv | 2.04% | Exit | 0 | $47.57 | $35M | −730,990 | −$35M |
| DXC - Dxc Technology | 1.46% | Exit | 0 | $20.83 | $25M | −1,198,173 | −$25M |
Filings history
19 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 40 | $3.1B | +11.5% | 13F-HR | 8/13/2026 | 000185479426000005 |
| 2026 Q1 | 40 | $2.7B | +5.6% | 13F-HR | 5/14/2026 | 000185479426000004 |
| 2025 Q4 | 40 | $2.6B | +3.7% | 13F-HR | 2/13/2026 | 000185479426000003 |
| 2025 Q3 | 41 | $2.5B | +12.7% | 13F-HR | 10/30/2025 | 000185479425000004 |
| 2025 Q2 | 40 | $2.2B | +13.9% | 13F-HR | 8/13/2025 | 000108514625004963 |
| 2025 Q1 | 39 | $1.9B | −10.2% | 13F-HR | 5/14/2025 | 000108514625003124 |
| 2024 Q4 | 43 | $2.2B | +6.4% | 13F-HR | 2/14/2025 | 000108514625001553 |
| 2024 Q3 | 41 | $2B | +8.2% | 13F-HR | 11/14/2024 | 000108514624005800 |
| 2024 Q2 | 40 | $1.9B | −8.3% | 13F-HR | 8/14/2024 | 000108514624003874 |
| 2024 Q1 | 42 | $2.1B | +8.8% | 13F-HR | 5/15/2024 | 000108514624002548 |
| 2023 Q4 | 43 | $1.9B | +10.8% | 13F-HR | 2/14/2024 | 000108514624001375 |
| 2023 Q3 | 42 | $1.7B | −5.2% | 13F-HR | 11/14/2023 | 000108514623004442 |
| 2023 Q2 | 44 | $1.8B | +702.2% | 13F-HR | 8/14/2023 | 000108514623003400 |
| 2023 Q1 | 42 | $224M | +8.7% | 13F-HR | 5/15/2023 | 000108514623002385 |
| 2022 Q4 | 43 | $206M | +3.0% | 13F-HR | 2/14/2023 | 000108514623001252 |
| 2022 Q3 | 42 | $200M | −11.5% | 13F-HR | 11/14/2022 | 000108514622004043 |
| 2022 Q2 | 42 | $226M | −23.4% | 13F-HR | 8/15/2022 | 000108514622003092 |
| 2022 Q1 | 45 | $295M | −15.0% | 13F-HR | 5/16/2022 | 000108514622002149 |
| 2021 Q4 | 43 | $347M | — | 13F-HR | 2/14/2022 | 000108514622001017 |
About
Patient Capital Management, LLC
19 processed 13Fs on this site · 2021 Q4–2026 Q2